These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 24573171
1. Effects of topical sphingosine-1-phosphate 1 receptor agonist on corneal allograft in mice. Jia L, Liu Y, Wang L, Zhu J, Huang Y. Cornea; 2014 Apr; 33(4):398-404. PubMed ID: 24573171 [Abstract] [Full Text] [Related]
2. Systemic application of sphingosine 1-phosphate receptor 1 immunomodulator inhibits corneal allograft rejection in mice. Zhu J, Liu Y, Pi Y, Jia L, Wang L, Huang Y. Acta Ophthalmol; 2014 Feb; 92(1):e12-21. PubMed ID: 23910624 [Abstract] [Full Text] [Related]
3. Topical application of sphingosine 1-phosphate receptor 1 prolongs corneal graft survival in mice. Zhu J, Liu Y, Huang Y. Mol Med Rep; 2015 May; 11(5):3800-7. PubMed ID: 25607596 [Abstract] [Full Text] [Related]
4. Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice. Liu Y, Jiang J, Xiao H, Wang X, Li Y, Gong Y, Wang D, Huang Y. Mol Vis; 2012 May; 18():624-33. PubMed ID: 22509094 [Abstract] [Full Text] [Related]
5. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival. Lan YY, Tokita D, Wang Z, Wang HC, Zhan J, Brinkmann V, Thomson AW. Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829 [Abstract] [Full Text] [Related]
6. Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist. Gao M, Liu Y, Xiao Y, Han G, Jia L, Wang L, Lei T, Huang Y. PLoS One; 2014 Nov; 9(9):e105693. PubMed ID: 25216235 [Abstract] [Full Text] [Related]
7. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K. J Immunol; 1998 Jun 01; 160(11):5493-9. PubMed ID: 9605152 [Abstract] [Full Text] [Related]
8. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant]. Shi W, Xie L, Wang S. Zhonghua Yan Ke Za Zhi; 2002 Aug 01; 38(8):502-5. PubMed ID: 12410993 [Abstract] [Full Text] [Related]
10. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Comer RM, King WJ, Ardjomand N, Theoharis S, George AJ, Larkin DF. Invest Ophthalmol Vis Sci; 2002 Apr 01; 43(4):1095-103. PubMed ID: 11923251 [Abstract] [Full Text] [Related]
11. Use of topical FK506 in a corneal graft rejection model in Lewis rats. Hikita N, Lopez JS, Chan CC, Mochizuki M, Nussenblatt RB, de Smet MD. Invest Ophthalmol Vis Sci; 1997 Apr 01; 38(5):901-9. PubMed ID: 9112986 [Abstract] [Full Text] [Related]
12. [Immunosuppressive effect of S1P1 receptor agonist FTY720]. Zhou WQ, Zhang HJ, Jin J, Li Y, Li C, Chen XG. Yao Xue Xue Bao; 2012 Apr 01; 47(4):546-50. PubMed ID: 22799042 [Abstract] [Full Text] [Related]
13. Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation. Song J, Hagiya H, Kurata H, Mizuno H, Ito T. Transpl Immunol; 2012 Mar 01; 26(2-3):163-70. PubMed ID: 22210496 [Abstract] [Full Text] [Related]
14. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J, Isobe M, Yamagami S, Mizuochi T, Tsuru T. Exp Eye Res; 1997 Jul 01; 65(1):89-98. PubMed ID: 9237869 [Abstract] [Full Text] [Related]
15. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats. Bourges JL, Lallemand F, Agla E, Besseghir K, Dumont JM, BenEzra D, Gurny R, Behar-Cohen F. Mol Vis; 2006 Dec 02; 12():1461-6. PubMed ID: 17167400 [Abstract] [Full Text] [Related]
16. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Di Tommaso C, Bourges JL, Valamanesh F, Trubitsyn G, Torriglia A, Jeanny JC, Behar-Cohen F, Gurny R, Möller M. Eur J Pharm Biopharm; 2012 Jun 02; 81(2):257-64. PubMed ID: 22445900 [Abstract] [Full Text] [Related]
17. Adoptive transfer of donor corneal antigen-specific regulatory T cells can prolong mice corneal grafts survival. He Y, Jie Y, Wang B, Zeng H, Zhang Y, Pan Z. Cornea; 2010 Nov 02; 29 Suppl 1():S25-31. PubMed ID: 20935538 [Abstract] [Full Text] [Related]
18. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function. Silva FR, Silva LB, Cury PM, Burdmann EA, Bueno V. Int Immunopharmacol; 2006 Dec 20; 6(13-14):1911-8. PubMed ID: 17161344 [Abstract] [Full Text] [Related]
19. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts. Huang WH, Yan Y, De Boer B, Bishop GA, House AK. Transplantation; 2003 Feb 15; 75(3):368-74. PubMed ID: 12589161 [Abstract] [Full Text] [Related]
20. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model. Shi W, Chen M, Xie L. Graefes Arch Clin Exp Ophthalmol; 2007 Nov 15; 245(11):1691-7. PubMed ID: 17541621 [Abstract] [Full Text] [Related] Page: [Next] [New Search]